The packaging solution allows a temperature of -20°C to be maintained in the shipping process. Credit: GiveWell/commons.wikipedia.

Thermal shipping solution provider CSafe has revealed that it is providing a cold-chain solution for Krystal Biotech’s Vyjuvek gene therapy.

Named CSafe CGT Ultra, the custom thermal container for Krystal features Vacuum Insulated Panel technology and simplified product handling.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

In addition, the customised solution helps to maintain a temperature of -20°C during the product’s journey.

CSafe is also launching its Retest & Reuse programme to further improve the supply chain of Vyjukek.

As part of the programme, CSafe leverages reusable shippers that preserve thermal performance.

The company’s expert team will inspect, clean and thermally requalify the insulation and shippers to ensure thermal integrity before reusing them.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to CSafe, this solution reduces avoidable landfill waste, making it an efficient and environmentally responsible packaging programme.

CSafe CEO Patrick Schafer said: “Cell and gene therapies are a core focus for CSafe, and we’re honoured to support Krystal Biotech and their transformative treatment.

“Using innovative engineering concepts, the CSafe team is able to stay at the forefront of both biopharmaceutical innovation and sustainability approaches.

“We’re pleased to support the most advanced therapies with the most advanced solutions for the sustainable, high-performance cold chain.”

In 2016, CSafe purchased cold chain packaging solutions provider Kalibox.